<?xml version='1.0' encoding='UTF-8'?>
<Organism_Record>
  <Organism_ID>ASD11870000_1</Organism_ID>
  <Organism>Staphylococcus aureus</Organism>
  <Organism_Latin>Staphylococcus aureus</Organism_Latin>
  <UniProt_ID>Q54113</UniProt_ID>
  <Seq_Length>668</Seq_Length>
  <Molecule_Weight>76103</Molecule_Weight>
  <KEGG_ID>sav:SAV0041</KEGG_ID>
  <Orthology_ID>K02545</Orthology_ID>
  <Pfam_ID>PF05223:MecA_N@@PF03717:PBP_dimer@@PF00905:Transpeptidase</Pfam_ID>
  <Allosteric_Activator_Count>2</Allosteric_Activator_Count>
  <Allosteric_Inhibitor_Count>0</Allosteric_Inhibitor_Count>
  <Allosteric_Regulator_Count>0</Allosteric_Regulator_Count>
  <Alias_List>
      <Alias>Penicillin binding protein 2 prime</Alias>
  </Alias_List>
  <Function_List>
    <Funtion>
      <Detail>Interacting selectively and non-covalently with penicillin, any antibiotic that contains the condensed beta-lactamthiazolidine ring system.</Detail>
      <Keyword>Penicillin binding</Keyword>
      <Ontology_ID>GO:0008658</Ontology_ID>
    </Funtion>
  </Function_List>
  <BioProcess_List>
    <BioProcess>
      <Detail>A change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an antibiotic stimulus. An antibiotic is a chemical substance produced by a microorganism which has the capacity to inhibit the growth of or to kill other microorganisms.</Detail>
      <Keyword>Response to antibiotic</Keyword>
      <Ontology_ID>GO:0046677</Ontology_ID>
    </BioProcess>
  </BioProcess_List>
  <Molecule_Seq>
    <Protein_Seq>MKKIKIVPLILIVVVVGFGIYFYASKDKEINNTIDAIEDKNFKQVYKDSSYISKSDNGEVEMTERPIKIYNSLGVKDINIQDRKIKKVSKNKKRVDAQYKIKTNYGNIDRNVQFNFVKEDGMWKLDWDHSVIIPGMQKDQSIHIENLKSERGKILDRNNVELANTGTAYEIGIVPKNVSKKDYKAIAKELSISEDYIKQQMDQNWVQDDTFVPLKTVKKMDEYLSDFAKKFHLTTNETESRNYPLGKATSHLLGYVGPINSEELKQKEYKGYKDDAVIGKKGLEKLYDKKLQHEDGYRVTIVDDNSNTIAHTLIEKKKKDGKDIQLTIDAKVQKSIYNNMKNDYGSGTAIHPQTGELLALVSTPSYDVYPFMYGMSNEEYNKLTEDKKEPLLNKFQITTSPGSTQKILTAMIGLNNKTLDDKTSYKIDGKGWQKDKSWGGYNVTRYEVVNGNIDLKQAIESSDNIFFARVALELGSKKFEKGMKKLGVGEDIPSDYPFYNAQISNKNLDNEILLADSGYGQGEILINPVQILSIYSALENNGNINAPHLLKDTKNKVWKKNIISKENINLLTDGMQQVVNKTHKEDIYRSYANLIGKSGTAELKMKQGETGRQIGWFISYDKDNPNMMMAINVKDVQDKGMASYNAKISGKVYDELYENGNKKYDIDE</Protein_Seq>
  </Molecule_Seq>
  <Gene>
    <Gene_Name>mecA</Gene_Name>
    <Genbank_ACCN>NC_002758</Genbank_ACCN>
    <Protein_ACCN>NP_370565</Protein_ACCN>
    <EMBL_ID>SAV0041</EMBL_ID>
  </Gene>
  <PDB_List>
    <PDB>
      <PDB_Title>Crystal structure of PBP2a from MRSA in complex with peptidoglycan analogue at allosteric</PDB_Title>
      <PDB_ID>3ZG5</PDB_ID>
      <Resolution>2.55</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3ZG5</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>How Allosteric Control of Staphylococcus Aureus Penicillin Binding Protein 2A Enables Methicillin Resistance and Physiological Function</PubMed_Title>
      <Author>Otero, L.H., et al.</Author>
      <Journal>Proc.Natl.Acad.Sci.USA(2013)110:16808</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/24085846?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal structure of ceftaroline acyl-PBP2a from MRSA with non- covalently bound ceftaroline and muramic acid at allosteric site obtained by soaking</PDB_Title>
      <PDB_ID>3ZFZ</PDB_ID>
      <Resolution>2.25</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3ZFZ</PDB_URL>
      <Has_Ligand>Yes</Has_Ligand>
      <ASD_Ligand>ASD11870002;ASD11870001</ASD_Ligand>
      <PubMed_Title>How Allosteric Control of Staphylococcus Aureus Penicillin Binding Protein 2A Enables Methicillin Resistance and Physiological Function</PubMed_Title>
      <Author>Otero, L.H., et al.</Author>
      <Journal>Proc.Natl.Acad.Sci.USA(2013)110:16808</Journal>
      <PubMed_ID>24085846</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal structure of PBP2a double clinical mutant N146K-E150K from MRSA</PDB_Title>
      <PDB_ID>4CPK</PDB_ID>
      <Resolution>2.35</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=4CPK</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Disruption of Allosteric Response as an Unprecedented Mechanism of Resistance to Antibiotics.</PubMed_Title>
      <Author>Fishovitz, J., et al.</Author>
      <Journal>J.Am.Chem.Soc.(2014)136:9814</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/24955778?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal structure of PBP2a clinical mutant N146K from MRSA</PDB_Title>
      <PDB_ID>4BL3</PDB_ID>
      <Resolution>3.0</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=4BL3</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Disruption of Allosteric Response as an Unprecedented Mechanism of Resistance to Antibiotics.</PubMed_Title>
      <Author>Fishovitz, J., et al.</Author>
      <Journal>J.Am.Chem.Soc.(2014)136:9814</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/24955778?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal structure of PBP2a clinical mutant E150K from MRSA</PDB_Title>
      <PDB_ID>4BL2</PDB_ID>
      <Resolution>2.72</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=4BL2</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Disruption of Allosteric Response as an Unprecedented Mechanism of Resistance to Antibiotics.</PubMed_Title>
      <Author>Fishovitz, J., et al.</Author>
      <Journal>J.Am.Chem.Soc.(2014)136:9814</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/24955778?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal structure of ceftaroline acyl-PBP2a from MRSA with non- covalently bound ceftaroline and muramic acid at allosteric site obtained by cocrystallization</PDB_Title>
      <PDB_ID>3ZG0</PDB_ID>
      <Resolution>2.6</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3ZG0</PDB_URL>
      <Has_Ligand>Yes</Has_Ligand>
      <ASD_Ligand>ASD11870002;ASD11870001</ASD_Ligand>
      <PubMed_Title>How Allosteric Control of Staphylococcus Aureus Penicillin Binding Protein 2A Enables Methicillin Resistance and Physiological Function</PubMed_Title>
      <Author>Otero, L.H., et al.</Author>
      <Journal>Proc.Natl.Acad.Sci.USA(2013)110:16808</Journal>
      <PubMed_ID>24085846</PubMed_ID>
    </PDB>
  </PDB_List>
  <Network_List>
    <Network>
      <Pathway_ID>ko01501</Pathway_ID>
      <Pathway_Title>beta-Lactam resistance</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Drug resistance</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko01501</Pathway_ID>
      <Pathway_Title>beta-Lactam resistance</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Drug resistance</Pathway_Subclass>
    </Network>
  </Network_List>
  <AllostericSite_List>
    <AllostericSite>
      <PDB_ID>3ZFZ;3ZG0</PDB_ID>
    </AllostericSite>
  </AllostericSite_List>
  <Modulator_List>
    <Modulator>
      <ASD_ID>ASD11870001</ASD_ID>
      <Modulator_Feature>Activator</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD11870002</ASD_ID>
      <Modulator_Feature>Activator</Modulator_Feature>
    </Modulator>
  </Modulator_List>
  <Create_Date>2015-04-08</Create_Date>
</Organism_Record>